To validate the impressive results of MTHFD2 transcript, we investigated the protein pattern in 117 RCC tissues through immunohistochemistry, which is a low-cost method used to complement pathological diagnosis of cancer [44, 45]. This evidence concerns the gene MTHFD2 and renal cell carcinoma.